These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 30699418)

  • 1. Clearance of Magnesium in Peritoneal Dialysis Patients: A Single-Center Study.
    Li G; Zhang L; Ren H; Huang B; Mao C; Zhou A
    Blood Purif; 2019; 47 Suppl 1(Suppl 1):1-7. PubMed ID: 30699418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drain volume required for a target peritoneal clearance: formulae based on peritoneal transport type and body size.
    Tzamaloukas AH; Malhotra D; Murata GH
    ASAIO J; 1998; 44(6):828-34. PubMed ID: 9831093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnesium homeostasis in patients undergoing continuous ambulatory peritoneal dialysis: role of the dialysate magnesium concentration.
    Katopodis KP; Koliousi EL; Andrikos EK; Pappas MV; Elisaf MS; Siamopoulos KC
    Artif Organs; 2003 Sep; 27(9):853-7. PubMed ID: 12940910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between the serum parathyroid hormone and magnesium levels in continuous ambulatory peritoneal dialysis (CAPD) patients using low-magnesium peritoneal dialysate.
    Cho MS; Lee KS; Lee YK; Ma SK; Ko JH; Kim SW; Kim NH; Choi KC
    Korean J Intern Med; 2002 Jun; 17(2):114-21. PubMed ID: 12164088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Body surface area limitations in achieving adequate therapy in peritoneal dialysis patients.
    Rocco MV
    Perit Dial Int; 1996; 16(6):617-22. PubMed ID: 8981531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of serum ionized magnesium in CAPD patients.
    Saha HH; Harmoinen AP; Pasternack AI
    Perit Dial Int; 1997; 17(4):347-52. PubMed ID: 9284461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical performance measures: the changing status of peritoneal dialysis.
    Flanigan MJ; Rocco MV; Prowant B; Frederick PR; Frankenfield DL
    Kidney Int; 2001 Dec; 60(6):2377-84. PubMed ID: 11737613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum Magnesium Abnormality and Influencing Factors of Serum Magnesium Level in Peritoneal Dialysis Patients: A Single-Center Study in Northern China.
    Tsai S; Zhao H; Wu B; Zuo L; Wang M
    Blood Purif; 2018; 45(1-3):110-117. PubMed ID: 29241212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adequacy and nutrition in the absence of residual renal function in peritoneal dialysis.
    Canale R; Barone RJ; Gimenez NS; Santopietro M; Ramirez L; Palliotti A; Romero P; Amado D
    Adv Perit Dial; 2001; 17():230-4. PubMed ID: 11510282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dialysis adequacy indices in high membrane transporters treated with short-dwell peritoneal dialysis.
    Strauss FG; Holmes DL; Dennis RL
    Adv Perit Dial; 1995; 11():110-3. PubMed ID: 8534681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peritoneal transport status influence on atherosclerosis/inflammation in CAPD patients.
    Sezer S; Tutal E; Arat Z; Akçay A; Celik H; Ozdemir FN; Haberal M
    J Ren Nutr; 2005 Oct; 15(4):427-34. PubMed ID: 16198934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between inflammation and changes in residual renal function and peritoneal transport rate during the first year of dialysis.
    Chung SH; Heimbürger O; Stenvinkel P; Bergström J; Lindholm B
    Nephrol Dial Transplant; 2001 Nov; 16(11):2240-5. PubMed ID: 11682675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peritoneal Phosphate Clearance: Determinants and Association With Mortality.
    Li J; Zhang W; Wang X; Sun N; Li L; Chang W
    Semin Dial; 2024; 37(3):259-268. PubMed ID: 38506151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High correlation between clearance of renal protein-bound uremic toxins (indoxyl sulfate and p-cresyl sulfate) and renal water-soluble toxins in peritoneal dialysis patients.
    Huang WH; Hung CC; Yang CW; Huang JY
    Ther Apher Dial; 2012 Aug; 16(4):361-7. PubMed ID: 22817125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of peritoneal membrane transport characteristics on acid-base status in CAPD patients.
    Kang DH; Yoon KI; Lee HY; Han DS
    Perit Dial Int; 1998; 18(3):294-302. PubMed ID: 9663894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimating the daily dialysate drain volume required in CAPD for a target peritoneal creatinine clearance by body water and peritoneal transport characteristics.
    Rao P; Tzamaloukas AH; Murata GH; Piraino B; Malhotra D; Bernardini J; Oreopoulos DG
    Adv Perit Dial; 1997; 13():33-7. PubMed ID: 9360647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between residual renal function, inflammation and patient survival in new peritoneal dialysis patients.
    Chung SH; Heimbürger O; Stenvinkel P; Qureshi AR; Lindholm B
    Nephrol Dial Transplant; 2003 Mar; 18(3):590-7. PubMed ID: 12584284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peritoneal membrane phosphate transport status: a cornerstone in phosphate handling in peritoneal dialysis.
    Bernardo AP; Contesse SA; Bajo MA; Rodrigues A; Del Peso G; Ossorio M; Cabrita A; Selgas R
    Clin J Am Soc Nephrol; 2011 Mar; 6(3):591-7. PubMed ID: 21115631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypomagnesemia in continuous ambulatory peritoneal dialysis patients dialyzed with a low-magnesium peritoneal dialysis solution.
    Ejaz AA; McShane AP; Gandhi VC; Leehey DJ; Ing TS
    Perit Dial Int; 1995; 15(1):61-4. PubMed ID: 7734563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peritoneal membrane characteristics in patients on peritoneal dialysis.
    Al-wakeel J; Al-Ghonaim M; Al-Suwaida A; Askar A; Usama S; Feraz N; Shah IH; Memon N; Qudsi A; Sulaimani F
    Saudi J Kidney Dis Transpl; 2011 Jan; 22(1):49-53. PubMed ID: 21196612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.